Prelude Capital Management, LLC Thermo Genesis Holdings, Inc. Transaction History

Prelude Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$1.98 - $2.92 $51,070 - $75,315	-25,793 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.9 - $6.4 $74,799 - $165,075	25,793 New	25,793 $75,000

Ticker THMO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,321,400
Description
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.